SAN DIEGO , Aug. 8, 2024 /PRNewswire/ -- Angiex, a developer of Nuclear-Delivered Antibody-Drug Conjugate™ (ND-ADC) therapies for solid cancers, announced that patient dosing has begun for their Phase 1 clinical trial of AGX101, a ...
Summary T-Maximum Pharmaceutical develops allogeneic CAR-T therapies with a unique CRISPR/Cas9 Gene-Editing platform for solid tumors, provide a solution of two major pain points, GvHD and HvG, aiming to revolutionize cancer. MT027, the ...
The groundbreaking pure C15:0 supplement from Seraphina Therapeutics raises C15:0 levels and supports liver and red blood cell health in independently run clinical trial at the University of California, San Diego SAN DIEGO , Aug. 6, ...
Raising dietary intake and circulating levels of C15:0, an essential fatty acid, improved liver health among young adults with overweight and obesity. SAN DIEGO , Aug. 6, 2024 /PRNewswire-PRWeb/ -- A highly anticipated clinical trial ...
Omnichannel partnership streamlines recruitment by connecting millions of patients worldwide to relevant research opportunities MALMO, Sweden and NEW YORK , Aug. 6, 2024 /PRNewswire-PRWeb/ -- Trialbee , the global leader in ...
Additional analyses of clinical and microbiological data from the Phase 2b segment show favorable gut microbiome changes including increased relative proportion of Actinobacteria in ibezapolstat-treated patients with C. difficile ...
WUHAN, China , June 24, 2024 /PRNewswire/ -- On June 20 (UTC-4), the U.S. Food and Drug Administration (FDA) approved the IND application for NouvNeu001, a cell therapy product from iRegene therapeutics targeting Parkinson's Disease. ...
SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- Novotech , the global full-service Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, today ...
CAMBRIDGE, Mass. , May 30, 2024 /PRNewswire/ -- ConcertAI, the leader in oncology predictive and generative AI SaaS and Real-World Data (RWD) Solutions for clinical research, announced the results of the study to be presented at the ASCO ...
J&J will gain full rights to develop, manufacture and commercialize NM26 globally for the treatment of atopic dermatitis and follow-on indications Under the agreement terms, J&J will pay $1.25 billion to acquire Yellow Jersey ...
A new clinical trial explores whether targeted steam therapy can offer a less invasive, effective treatment for prostate cancer.
Vanderbilt’s Phase I trial of VU319 demonstrates promising results for Alzheimer’s and schizophrenia
Late-breaking research finds no survival benefit from autologous stem cell transplant in mantle cell lymphoma patients with undetectable MRD.
Hypovolemic phlebotomy, removing 10% of blood before liver surgery, can cut transfusion needs by 50%, offering a safe, cost-effective way to reduce surgery risks.
Felzartamab, an investigational antibody, reduces triggers linked to IgA nephropathy, an autoimmune kidney disease, suggesting lasting clinical benefits.
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers